Testing effectiveness (Phase 2)Study completedNCT02383498What this trial is testingQUILT-3.011 Phase 2 Yeast-Brachyury Vaccine ChordomaWho this might be right forChordoma NantCell, Inc. 24
Testing effectiveness (Phase 2)WithdrawnNCT03647423What this trial is testingQUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.Who this might be right forChordomaUnresectable Malignant Neoplasm ImmunityBio, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT05041127What this trial is testingCetuximab for the Treatment of Advanced Unresectable or Metastatic ChordomaWho this might be right forChordomaMetastatic ChordomaUnresectable Chordoma M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)UnknownNCT04042597What this trial is testingAnlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic ChordomaWho this might be right forEffect of DrugsQuality of LifeChordoma+1 more Peking University People's Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03623854What this trial is testingNivolumab and Relatlimab in Treating Participants With Advanced ChordomaWho this might be right forChordomaLocally Advanced ChordomaMetastatic Chordoma+1 more Jonsson Comprehensive Cancer Center 10
Early research (Phase 1)Ended earlyNCT00003926What this trial is testingAmifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more Masonic Cancer Center, University of Minnesota 13